Compare ULY & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ULY | ACON |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 4.4M |
| IPO Year | N/A | 2022 |
| Metric | ULY | ACON |
|---|---|---|
| Price | $2.04 | $5.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $11.50 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 68.8K | 66.3K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $127,932,000.00 | $67,483.00 |
| Revenue This Year | N/A | $145.39 |
| Revenue Next Year | $18.95 | $145.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.91 |
| 52 Week Low | $1.74 | $5.55 |
| 52 Week High | $17.99 | $3,499.49 |
| Indicator | ULY | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 42.25 | 42.43 |
| Support Level | $1.85 | $5.75 |
| Resistance Level | $3.13 | $6.89 |
| Average True Range (ATR) | 0.30 | 0.62 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 21.01 | 7.14 |
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.